Literature DB >> 16536051

GFAP expression in the liver as an early marker of stellate cells activation.

Sergio Morini1, Simone Carotti, Guido Carpino, Antonio Franchitto, Stefano Ginanni Corradini, Manuela Merli, Eugenio Gaudio.   

Abstract

The activation of hepatic stellate cells is the conversion of quiescent cells into proliferative, contractile, and fibrogenic myofibroblasts. The alpha-smooth muscle actin is a well known marker of hepatic stellate cells activation. On the other hand, the Glial Fibrillary Acidic Protein expression is a key step in the astrocytes differentiation and constitutes the hallmark response of astrocytes to injury. Glial Fibrillary Acidic Protein expression was reported in quiescent stellate cells in vivo, with an increased expression in the acute response to injury in the rat, and a down-regulation in the chronic one. This study aims to evaluate the morphologic characteristics, distribution and percentage of Glial Fibrillary Acidic Protein expressing cells in normal and injured human livers. Human liver biopsies (n=32) were divided in three groups: 1) donors liver; 2) chronic hepatitis C-virus related; 3) post-viral hepatitis cirrhosis. Samples were immunostained with anti- alpha-smooth muscle actin and anti- Glial Fibrillary Acidic Protein antibody. Subsequently they were semi-quantitatively evaluated. Liver fibrosis was quantified by morphometric analysis. In chronic hepatitis livers and in the cirrhotic ones, hepatic stellate cells became larger with long cytoplasmic processes. The alpha-smooth muscle actin -positive stellate cells increase and expand from areas of piecemeal necrosis to the entire residual parenchyma with the progression of the fibrosis. By contrast Glial Fibrillary Acidic Protein-positive stellate cells are more evenly distributed in the earlier stages and confined to the periphery of the hepatic lobule in the advanced ones. Also some endothelial cells were Glial Fibrillary Acidic Protein positive in vessels of the expanding septa and at the edges of cirrhotic nodules. Glial Fibrillary Acidic Protein expression in the liver is probably linked to the fine modulation of the cytoskeleton during the formation of cytoplasmic processes in both stellate cells and endothelial cells. In the latter Glial Fibrillary Acidic Protein expression might be related to the remodelling of the vascular bed that occurs during the response to injuries. Otherwise in hepatic stellate cells it seems to be a marker related with the acquisition of contractile properties in a subpopulation more closely associated with precocious stages of the fibrosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16536051

Source DB:  PubMed          Journal:  Ital J Anat Embryol        ISSN: 1122-6714


  21 in total

1.  Knockout of the Tachykinin Receptor 1 in the Mdr2-/- (Abcb4-/-) Mouse Model of Primary Sclerosing Cholangitis Reduces Biliary Damage and Liver Fibrosis.

Authors:  Ludovica Ceci; Heather Francis; Tianhao Zhou; Thao Giang; Zhihong Yang; Fanyin Meng; Nan Wu; Lindsey Kennedy; Konstantina Kyritsi; Vik Meadows; Chaodong Wu; Suthat Liangpunsakul; Antonio Franchitto; Amelia Sybenga; Burcin Ekser; Romina Mancinelli; Paolo Onori; Eugenio Gaudio; Shannon Glaser; Gianfranco Alpini
Journal:  Am J Pathol       Date:  2020-07-23       Impact factor: 4.307

2.  Peroxisome proliferator-activated receptor agonist treatment of alcohol-induced hepatic insulin resistance.

Authors:  Suzanne M de la Monte; Maoyin Pang; Rajeev Chaudhry; Kevin Duan; Lisa Longato; Jade Carter; Jiyun Ouh; Jack R Wands
Journal:  Hepatol Res       Date:  2011-02-24       Impact factor: 4.288

3.  New Mechanism of Hepatic Fibrogenesis: Hepatitis C Virus Infection Induces Transforming Growth Factor β1 Production through Glucose-Regulated Protein 94.

Authors:  Min Hyeok Jee; Ka Young Hong; Ji Hoon Park; Jae Seung Lee; Hee Sun Kim; Song Hee Lee; Sung Key Jang
Journal:  J Virol       Date:  2015-12-30       Impact factor: 5.103

4.  Therapeutic effects of vitamin A on experimental cholestatic rats with hepatic fibrosis.

Authors:  Ken-ichi Murakami; Tatsuru Kaji; Ryuichi Shimono; Yoshihiro Hayashida; Hiroshi Matsufuji; Shinichiro Tsuyama; Rie Maezono; Ken-ichiro Kosai; Hideo Takamatsu
Journal:  Pediatr Surg Int       Date:  2011-02-03       Impact factor: 1.827

5.  Identification of regulators of chaperone-mediated autophagy.

Authors:  Urmi Bandyopadhyay; Sunandini Sridhar; Susmita Kaushik; Roberta Kiffin; Ana Maria Cuervo
Journal:  Mol Cell       Date:  2010-08-27       Impact factor: 17.970

6.  Rat strain differences in susceptibility to alcohol-induced chronic liver injury and hepatic insulin resistance.

Authors:  Sarah M Denucci; Ming Tong; Lisa Longato; Margot Lawton; Mashiko Setshedi; Rolf I Carlson; Jack R Wands; Suzanne M de la Monte
Journal:  Gastroenterol Res Pract       Date:  2010-08-16       Impact factor: 2.260

7.  Hepatic tumor-stroma crosstalk guides epithelial to mesenchymal transition at the tumor edge.

Authors:  F van Zijl; M Mair; A Csiszar; D Schneller; G Zulehner; H Huber; R Eferl; H Beug; H Dolznig; W Mikulits
Journal:  Oncogene       Date:  2009-08-31       Impact factor: 9.867

Review 8.  Senescence in hepatic stellate cells as a mechanism of liver fibrosis reversal: a putative synergy between retinoic acid and PPAR-gamma signalings.

Authors:  Concetta Panebianco; Jude A Oben; Manlio Vinciguerra; Valerio Pazienza
Journal:  Clin Exp Med       Date:  2016-09-21       Impact factor: 3.984

9.  Regulatory T cells prevent liver fibrosis during HIV type 1 infection in a humanized mouse model.

Authors:  Jun-Ichi Nunoya; Michael L Washburn; Grigoriy I Kovalev; Lishan Su
Journal:  J Infect Dis       Date:  2013-10-16       Impact factor: 5.226

10.  Clinical significance and gene expression study of human hepatic stellate cells in HBV related-hepatocellular carcinoma.

Authors:  Rui Liao; Han Wu; Yong Yi; Jia-Xing Wang; Xiao-Yan Cai; Hong-Wei He; Yun-Feng Cheng; Jian Zhou; Jia Fan; Jian Sun; Shuang-Jian Qiu
Journal:  J Exp Clin Cancer Res       Date:  2013-04-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.